Masashi Nakayama Selected Research

Adenocarcinoma

1/2023	Progressive Spreading of DNA Methylation in the GSTP1 Promoter CpG Island across Transitions from Precursors to Invasive Prostate Cancer.
9/2003	Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masashi Nakayama Research Topics

Disease

31	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 11/2003
27	Neoplasms (Cancer) 12/2023 - 02/2004
17	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 06/2007
11	Neoplasm Metastasis (Metastasis) 04/2022 - 06/2007
7	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 07/2006
6	Carcinoma (Carcinomatosis) 05/2024 - 11/2003
5	Lymphatic Metastasis 09/2021 - 04/2012
4	Disease Progression 05/2024 - 09/2010
4	Atrophy 01/2023 - 09/2003
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2009 - 11/2005
3	Prostatic Intraepithelial Neoplasia 01/2023 - 09/2003
3	Anemia 01/2023 - 01/2008
3	Carcinogenesis 02/2004 - 09/2003
2	Hepatitis 01/2024 - 09/2021
2	Adenocarcinoma 01/2023 - 09/2003
2	Lung Abscess 04/2022 - 05/2014
2	Lymphoma (Lymphomas) 02/2020 - 06/2007
2	Margins of Excision 01/2017 - 04/2012
2	Testicular Neoplasms (Testicular Cancer) 05/2014 - 06/2007
2	Residual Neoplasm 09/2013 - 06/2007
2	Carcinoma in Situ 03/2010 - 04/2009
2	Seminoma 01/2010 - 11/2008
2	Kidney Neoplasms (Kidney Cancer) 04/2009 - 06/2007
2	Inflammation (Inflammations) 06/2007 - 11/2003
1	Cytokine Release Syndrome 01/2024
1	Abdominal Pain (Pain, Abdominal) 01/2024
1	Renal Insufficiency (Renal Failure) 04/2023
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 04/2023
1	Signet Ring Cell Carcinoma 04/2023
1	Pneumothorax 04/2022
1	Pleural Empyema (Pyothorax) 04/2022
1	Fistula 04/2022
1	Pneumonia (Pneumonitis) 09/2021
1	Osteonecrosis (Kienbock's Disease) 03/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021

Drug/Important Bio-Agent (IBA)

6	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2008
6	NivolumabIBA 01/2023 - 07/2020
5	Axitinib (AG 013736)IBA 01/2024 - 10/2016
5	Hormones (Hormone)IBA 12/2023 - 06/2006
5	AndrogensIBA 12/2023 - 01/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2004
5	Prostate-Specific Antigen (Semenogelase)IBA 02/2020 - 08/2011
5	Proteins (Proteins, Gene)FDA Link 07/2015 - 09/2003
4	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 06/2007
4	Immune Checkpoint InhibitorsIBA 12/2022 - 10/2020
4	Dexamethasone (Maxidex)FDA LinkGeneric 08/2013 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 02/2004
3	NF-kappa B (NF-kB)IBA 01/2008 - 06/2006
2	avelumabIBA 05/2024 - 04/2023
2	nedaplatinIBA 04/2023 - 06/2007
2	Gemcitabine FDA Link 04/2023 - 11/2020
2	Glutathione S-Transferase piIBA 01/2023 - 09/2003
2	cabazitaxel FDA Link 01/2023 - 02/2020
2	IpilimumabIBA 10/2022 - 04/2022
2	Tyrosine Kinase InhibitorsIBA 11/2021 - 09/2021
2	Everolimus FDA Link 07/2020 - 10/2016
2	Sunitinib (Sutent)FDA Link 07/2020 - 10/2016
2	EnzymesIBA 05/2020 - 05/2007
2	Sorafenib (BAY 43-9006)FDA Link 10/2016 - 11/2012
2	InterferonsIBA 10/2016 - 02/2008
2	Estramustine FDA Link 02/2014 - 08/2013
2	Interferon-alpha (Interferon Alfa)IBA 09/2012 - 04/2009
2	Scavenger Receptors (Scavenger Receptor)IBA 06/2010 - 02/2009
2	Conditioned Culture MediaIBA 01/2010 - 06/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2009 - 01/2008
2	Messenger RNA (mRNA)IBA 04/2009 - 06/2005
2	Endothelin A ReceptorIBA 01/2008 - 06/2006
2	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2004 - 02/2004
1	PlatinumIBA 05/2024
1	pembrolizumabIBA 01/2024
1	tocilizumab (atlizumab)FDA Link 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 01/2024
1	Therapeutic UsesIBA 12/2023
1	CytosineIBA 01/2023
1	taxaneIBA 01/2023
1	GuanineIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	niraparibIBA 12/2022
1	Circulating Tumor DNAIBA 12/2022
1	ProteomeIBA 12/2022
1	Anti-Infective Agents (Microbicides)IBA 04/2022
1	Zoledronic Acid (Zometa)FDA Link 03/2021
1	Bone Density Conservation AgentsIBA 03/2021
1	Denosumab FDA Link 03/2021

Therapy/Procedure

28	Therapeutics 05/2024 - 01/2008
13	Drug Therapy (Chemotherapy) 05/2024 - 06/2007
8	Nephrectomy 01/2024 - 03/2009
8	Prostatectomy (Retropubic Prostatectomy) 01/2017 - 07/2006
6	Radiotherapy 12/2023 - 11/2009
6	Castration 01/2023 - 08/2013
3	Adjuvant Chemotherapy 11/2015 - 10/2012
2	Adrenalectomy 04/2020 - 01/2019
2	Oral Administration 02/2011 - 06/2007
2	Lasers (Laser) 05/2009 - 09/2003
2	Molecular Targeted Therapy 01/2008 - 06/2006
1	Drug Tapering 01/2024
1	Immunotherapy 04/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 04/2022